Recent Developments On Activatable Turn‐On Fluorogenic Donors of Hydrogen Sulfide (H2S)

Documenti analoghi

• Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
  di: K. Jagathesan, et al.
  Pubblicazione: (2024)
• Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation
  di: Prakash Shukla, et al.
  Pubblicazione: (2025)
• Front Cover: Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation (ChemMedChem 20/2025)
  di: Prakash Shukla, et al.
  Pubblicazione: (2025)
• A Donor–Donor‐π‐Acceptor–Acceptor Type Photosensitizer for Efficient Photo‐Inactivation of Pathogens Within Biofilms and Host Cells
  di: Yunli Xu, et al.
  Pubblicazione: (2026)
• Development of Keap1‐Nrf2 Protein–Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene‐2‐acetamide Scaffold, and its Anti‐Inflammatory Effects
  di: Daisuke Yasuda, et al.
  Pubblicazione: (2025)